Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE2

OBJECTIVES: Despite advances in antibody treatments and vaccines, COVID‐19 caused by SARS‐CoV‐2 infection remains a major health problem resulting in excessive morbidity and mortality and the emergence of new variants has reduced the effectiveness of current vaccines. METHODS: Here, as a proof‐of‐co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Karabacak, Fatih, Yigit, Mesut, Unutmaz, Derya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586837/
https://www.ncbi.nlm.nih.gov/pubmed/36285327
http://dx.doi.org/10.1002/cti2.1421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586837/
https://www.ncbi.nlm.nih.gov/pubmed/36285327
http://dx.doi.org/10.1002/cti2.1421

Ejemplares similares